Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
7.62
-0.42 (-5.22%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $6.89M in the quarter ending June 30, 2024, with 23.02% growth. This brings the company's revenue in the last twelve months to $35.19M, up 61.95% year-over-year. In the year 2023, Foghorn Therapeutics had annual revenue of $34.16M with 77.63% growth.

Revenue (ttm)
$35.19M
Revenue Growth
+61.95%
P/S Ratio
10.18
Revenue / Employee
$303,319
Employees
116
Market Cap
421.60M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sonida Senior Living 244.78M
Ginkgo Bioworks Holdings 184.34M
REGENXBIO 89.04M
OmniAb 21.71M
MeiraGTx Holdings 8.12M
Absci 3.25M
Revenue Rankings